secwatch / observer

8-K filed May 5, 2026, 7:59 PM ET ticker AVNS CIK 0001606498

earnings confidence low sentiment neutral materiality 0.25

Avanos Medical announces Q1 2026 results; filing includes no financial figures

AVANOS MEDICAL, INC.

2026-Q1 EPS reported $0.11 revenue$182,200,000

Press release issued May 5, 2026 covering three months ended March 31, 2026.
No specific revenue, EPS, or segment data available in the filing excerpt.
Investors should refer to the full press release for detailed results.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

AVANOS MEDICAL, INC. reported financial results for the three months ended March 31, 2026.

Period: the three months ended March 31, 2026
Result: reported results

Exact text from the filing

On May 5, 2026, Avanos Medical, Inc. issued a press release announcing its results of operations for the three months ended March 31, 2026.

View on SEC.gov

Browse all earnings releases →

AVANOS MEDICAL, INC. filing history →

Source: SEC EDGAR

accession 0001606498-26-000061

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.